Associated Papers
Gene therapy targeting synaptopathy linked with Alzheimer's and Parkinson's disease.
Panda SP et al.
Neuroscience, 2026
Hemoglobin as a pseudoperoxidase and drug target for oxidative stress-related diseases.
Won W et al.
Signal Transduction and Targeted Therapy, 2025
40846833 (PubMed )
Supplement: 41392_2025_2366_MOESM1_ESM.docx
The Role of Astrocytes and Alpha-Synuclein in Parkinson's Disease: A Review.
Brash-Arias D et al.
Neurosci, 2024
One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids.
Geurts MH et al.
Nature Communications, 2023
37591832 (PubMed )
Supplement: 41467_2023_40701_MOESM1_ESM.pdf
Protein Misfolding and Aggregation: The Relatedness between Parkinson's Disease and Hepatic Endoplasmic Reticulum Storage Disorders.
Padilla-Godínez FJ et al.
International Journal of Molecular Sciences, 2021
Role of lysosomes in physiological activities, diseases, and therapy.
Zhang Z et al.
Journal of Hematology & Oncology, 2021
Therapeutic Potential of Vital Transcription Factors in Alzheimer's and Parkinson's Disease With Particular Emphasis on Transcription Factor EB Mediated Autophagy.
Rai SN et al.
Frontiers in Neuroscience, 2021
Limelight on alpha-synuclein: pathological and mechanistic implications in neurodegeneration.
Wales P et al.
Journal of Parkinson's Disease, 2013
Select a paper to view details